socalTECH

MARCH 4, 2013

It might be, on news that Kevin Sharer , the former CEO of Thousand Oaks-based Amgen , has joined venture capital investment firm Foundation Medical Partners. Is Amgen the next source of the healthcare industry's venture capital deals? READ MORE>>.

Venture Capital

socalTECH

DECEMBER 17, 2013

Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease.

Thousand Oaks

socalTECH

FEBRUARY 22, 2012

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 The firm will start trading today on the NASDAQ Global Market as CERE.

Pricing

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. The startup is led by Sanjay D.

Thousand Oaks

socalTECH

NOVEMBER 12, 2018

179 structures were tallied as destroyed as of 10:00pm on Sunday evening, and hundreds of thousands of residents evacuated at one time, with continuing evacuations and displacements of entire cities and communities. READ MORE>>.

Southern California

socalTECH

JUNE 26, 2019

Thousand Oaks-based Amgen is helping two, Bay Area startups, by offering up lab space and access to its scientific and business leaders, as part of a program called the "Amgen Golden Ticket", the company said on Tuesday. Amgen says it has been been sponsoring MBC BioLabs since 2016.

Thousand Oaks

socalTECH

JANUARY 11, 2022

Thousand Oaks-based Amgen and share lab provider Biolabs LA said Monday that they have awarded Karma Biotechnologies one year of lab space at Biolabs, as well as other facility benefits and connections to Amgen's scientific and business leaders.

Thousand Oaks

socalTECH

OCTOBER 31, 2017

Thousand Oaks-based biotech giant a href="[link] said on Monday that it has agreed to acquire its joint venture with Kirin, Kirin-Amgen , in a deal worth $780M. According to Amgen, the deal will make Kirin-Amgen a wholly owned subsidiary of Amgen. Amgen said the $780M will come directly from Kirin-Amgen itself. READ MORE>>.

Thousand Oaks

socalTECH

DECEMBER 31, 2014

We''re continuing to feature reflections on the last year from movers and shakers in the local high tech community, and today have thoughts from Gerhard Apfelthaler , who is Dean of California Lutheran University''s School of Management , which has been very active in Ventura County helping to promote startup and entrepreneurial activity.

Westlake Village

socalTECH

OCTOBER 8, 2009

Thousand Oaks-based wireless network equipment provider Xirrus appears to be on a roll in signing up education customers, saying Wednesday that it has signed up Wasatch High School, located in Utah, as its latest customer. Xirrus is the latest startup of Xircom founder Dirk Gates. READ MORE>>.

Education

socalTECH

FEBRUARY 21, 2013

Xirrus , the wireless hardware provider based in Thousand Oaks, has just raised $10.1M in a funding round, part of an ongoing $11.0M funding, according to a regulatory filing by the company. Details on the funding have not yet been announced by the company.

Thousand Oaks

socalTECH

DECEMBER 31, 2012

in the company's efforts to start a commercial space tourism industry. generation of startups. SpaceX Plans Launch Site In Texas - In April, SpaceX announced plans to set up a launch. Ceres Closes IPO - Among the few Southern California IPOs, Thousand Oaks-based biofuels seed technology provider Ceres has its IPO in April.

Southern California

socalTECH

JUNE 23, 2016

Thousand Oaks-based biotech giant Amgen has put its backing behind a new, life sciences incubator, called QB3@953. QB3@953 provides lab space to life sciences startups, which Amgen says is a "key obstacle" for life sciences startups. Financial details of the sponsorship were not detailed. READ MORE>>.

Incubator

socalTECH

FEBRUARY 22, 2012

Thousand Oaks-based Xirrus , the developer of wireless networking equipment headed by Dirk Gates, has snagged the CEO of networking equipment maker Calix for its board. Xirrus said it has added Carl Russo, President and CEO of Calix, to the position. READ MORE>>.

Thousand Oaks

socalTECH

AUGUST 24, 2010

Tags: business startups calfiornia southern.

Southern California

SoCal Tech Calendar

DECEMBER 3, 2018

Wednesday, December 5, 2018 -- Startups: The Year That Was and The Year That's Ahead. Lundring Events Center, California Lutheran University, 130 Overton Court (inside Gilbert Sports and Fitness Center), Thousand Oaks. Cal Lutheran Center for Entrepreneurship. Wednesday, December 5, 6 - 8 p.m., See [link] (more)

Thousand Oaks

socalTECH

APRIL 20, 2017

Thousand Oaks-based wireless networking equipment maker Xirrus has been acquired by Riverbed , to help bolster its SD WAN efforts, the two said on Wednesday. Riverbed said it will continue to offer up Xirrus as a stand-alone enterprise WLAN solution. Financial terms of the acquisition were not announced. READ MORE>>.

Thousand Oaks

socalTECH

NOVEMBER 17, 2017

Amgen Ventures , the venture investment arm of Thousand Oaks-based Amgen , is one of the new investors in precision oncology and medicine startup Syapse.

Thousand Oaks

socalTECH

MARCH 8, 2016

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. According to Tizona Therapeutics, it completed a $43M Series B financing round, which was led by Abingworth and Canaan Partners.

Thousand Oaks

socalTECH

APRIL 29, 2021

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

Westlake Village

socalTECH

MARCH 4, 2016

IndieU , a new, Los Angeles area startup, is hoping to help connect local college students with independent artists. The startup recently launched a service, which lets college students follow the musical interest of their friends, create playlists, and stream and download independent songs for free, and find local independent musicians.

Thousand Oaks

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. Adheron said that it has been acquired by Roche , in a deal worth $105M upfront and up to $475M in additional milestone payments.

Thousand Oaks

socalTECH

JULY 25, 2018

Thousand Oaks-based AliveGen > , a startup developing biopharmacueticals to treat muscle and bone loss and the loss of functional capacity, has sold the rights two two of its early stage drug candidates to Biogen , in a deal worth as much as $562.5M. According to Biogen, it will pay $27.5M

Thousand Oaks

socalTECH

OCTOBER 12, 2016

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M in a Series A investment. The investment came from F-Prime Capital Partners.

Thousand Oaks

socalTECH

OCTOBER 29, 2015

Brett and I both grew up in Southern California. I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. How did you guys start the company? I came up with this idea due to a deep obsession with the mortgage industry. It's too big of an opportunity to pass up.

Southern California

Xconomy

JULY 22, 2016

But there’s plenty more to dig through as well, from a shakeup at Zafgen to a few new high profile startups and a newly public gene therapy company. It’s the first partnership for Jounce, and a big one: the startup got a $225 million up front cash payment from Celgene and a $36 million equity investment.

Startup

Tech Zulu Event

MARCH 21, 2010

DEMO has officially started today and we will be there starting tomorrow. Judging by the companies he has selected to launch on the DEMO stage he certainly is off to a great start. Invested.in; Thousand Oaks, California; www.invested.in. Austin, Texas; www.zosh.com. InfoDome; Oakland, California; www.InfoDome.com.

Cerritos

Xconomy

AUGUST 5, 2016

. —Gene therapy news: After investing in Bamboo Therapeutics and its Duchenne muscular dystrophy treatment earlier this year, Pfizer bought the Chapel Hill, NC-based biotech outright on Monday for $150 million up front , with potentially another $495 million later. His Chatham Therapeutics was acquired by Baxter International in 2014.

News

socalTECH

APRIL 29, 2014

We caught up with one of the local teams competing in that competition, VOXearch (www.voxearch.com), to learn more about the prize as well as their specific approach to the competition. Mike Outmesguine: We''re one of about thirty teams left in the challenge, out of more than 300 that signed up last August.

Startup

socalTECH

JANUARY 27, 2020

Bryant and his other passengers were on a helicopter traveling from John Wayne Airport, on the way to a basketball tournament for his daughter, which was being held at the Mamba Sports Academy in the Thousand Oaks area, and were inbound over the 101 freeway near Los Virgenes Road when, for some unknown reason, the helicopter they were flying in plunged (..)

Thousand Oaks

Xconomy

JUNE 10, 2016

—Meanwhile, check out reports here , here , and here for some of the other headlines coming out of ASCO, including progress made in cancer immunotherapy, the ups and downs from various presenting companies, and a visit from Vice President Joe Biden. Ed Silverman at STAT reported the analyst note first. .

Incubator

Xconomy

SEPTEMBER 30, 2016

—Amgen (NASDAQ: AMGN ), of Thousand Oaks, CA, and partner Novartis released positive results from the first Phase 3 trial of erenumab , one of a group of drugs being developed to prevent migraines , not just lessen their impact when they happen. . Phase 3 trials should start next year.

Avalon

Xconomy

AUGUST 26, 2016

Mylan bumped up the price of the EpiPen 400 percent, presidential nominee Hillary Clinton responded with a tirade against drug price hikes, and—much like when Clinton railed against drug pricing last year—biotech indexes promptly plummeted more than 3 percent. —Pfizer wasn’t done after scooping up Medivation.

Pricing